Table 1. Statistics of the distribution of datasets and biomarkers in CancerLivER.
| Distribution of datasets | |||||
|---|---|---|---|---|---|
| Based on liver cancer types | Based on types of transcripts | Based on profiling techniques | |||
| Hepatocellular carcinoma (HCC) | 111 | Coding | 45 | Affymetrix | 38 |
| Cholangiocarcinoma (CCA) | 5 | Non-coding | 25 | Illumina | 24 |
| Hepatoblastoma | 3 | Both | 45 | Agilent | 22 |
| Fibrolamellar hepatocellular carcinoma | 2 | High-throughput | 21 | ||
| Other array | 10 | ||||
| Distribution of biomarkers | |||||
| Based on type of Biomarkers | Based on biomolecule | Based on source of samples | |||
| Diagnostic | 341 | RNA | 315 | Tissue | 452 |
| Prognostic | 165 | Protein | 178 | Serum | 55 |
| Predictive | 51 | miRNA | 46 | Plasma | 52 |
| Both diagnostic and prognostic | 37 | Metabolite | 35 | Urine | 44 |
| lincRNA | 19 | Cell line or cells | 35 | ||
| Others | 8 | ||||